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I. Abstract  
New Zealand White rabbits were administered morphine, transdermal fentanyl 
patches, saline placebo injection, and placebo tegaderm patches respectively for eight 
weeks to test whether opioids effect cortical bone pore network structures within femora 
and tibiae.  
II. Introduction  
Cortical bone contains pore networks which attribute to their overall strength 
(Ammann and Rizzoli 2003). Varying structures of pore networks such as, number of 
branches, length, connectivity, and thickness is dependent on several variables, which 
can be biological or environmental (Khosla et al. 2006). The density and connectivity of 
an individual’s cortical pore network can vary widely depending on sex, age, diet, 
hormones, and substance use (Khosla et al. 2006). Bone remodeling, an ongoing tissue 
turnover process occurring throughout life, lends to the variation observed among pore 
networks between individuals. Bone remodeling is accomplished via bone effector cells 
- osteoblasts and osteoclasts - two cell types that reside within bone. Osteoclasts are 
responsible for bone-resorbing while osteoblasts are responsible for bone-forming and 
the two processes are in equilibrium. Although the two processes are in equilibrium 
bone formation lags in comparison to bone resorption, indicating a required balance 
(Stout and Crowder 2012). In atypical circumstances, such as in cases of metabolic 
bone disease or substance use (e.g., opioids), the equilibrium between the two 
processes can be disrupted therefore causing abnormalities within the structures of an 
individual’s bone pore network (Chrastil et al. 2013).  
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There has been a sharp increase since the 1990’s for written prescriptions for 
opioid analgesics (Paulozzi et al. 2006). Subsequently an increase in misuse of opioids 
followed. Recent studies estimate over one million people in the United States misuse 
opioids (National Institutes of Health 2018). In the United States deaths due to overdose 
involving opioids has increased 200% since 2002 (Rudd et al. 2016). The growing 
epidemic has led to a link between opioids and bone fragility. Opioid usage has been 
clinically demonstrated to influence the overall pore network within bones by disrupting 
the equilibrium the between resorption and formation of bone (Chrastil et al. 2013). 
Osteoblasts, bone-forming cells, possess opioid receptors which opioids interact with 
and inhibit bone formation. Additionally, opioids can inhibit the function of vasoactive 
intestinal peptide (VIP), a neuropeptide that stimulates osteogenesis and reduces 
osteoclast function. Neuropeptide Y (NPY) is another neuropeptide that stimulates 
osteogenesis and is inhibited by opioids (Coluzzi et al. 2020 Apr 6). Inhibition of bone 
formation can lead to deviations within pore networks. Opioids can also produce an 
endocrine effect that reduces estradiol levels in women and testosterone in men 
(Coluzzi et al. 2015). Transdermal fentanyl, which is known to have higher opioid 
activity than morphine, has been linked to androgen deficiency (Coluzzi et al. 2020 Apr 
6). Lower estradiol levels in women naturally occur with age, which leads to an increase 
risk of osteoporosis (Coluzzi et al. 2015).  
Previous research has failed to fully explain the effects of prolonged misuse of 
opioids on bone pore network microstructures. Opioids considerably reduce bone 
mineral density (BMD) in individuals (Kinjo et al. 2005). Since the presence of opioids 
disrupts bone formation it is predicted that the three-dimensional (3D) structure of pore 
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networks will also be disrupted. In order to explore this hypothesis using an in vivo live 
animal model, New Zealand white rabbits were utilized. 
 Cortical bone pore networks can be visualized in 3D using desktop micro-
Computed Tomography (µCT). Through employing this method, the number of 
branches, the length, connectivity between branches, and the thickness of pore 
networks will be quantified. The objective of the present study is to identify if prolonged 
use of opioids will cause an abnormal structure to pore networks within bone. It is 
hypothesized that due to osteoblast disruption, opioid rabbit bones will display less 
cortical pore connectivity, shorter and fewer connecting branches, and thinner pore 
networks. 
III. Materials and Methods  
Due to this project being a part of a larger ongoing project in Dr. Janna 
Andronowski’s lab some material and methods were excluded.  
SkyScan 1172 desktop micro-CT imaging  
 Clean femora and tibiae (void of adhering soft tissues) were stored in a -20°C 
freezer and thawed in the refrigerator 24 hours prior to imaging. Due to height 
restrictions associated with the µCT gantry, tibiae were trimmed distally for imaging 
using a Buehler Isomet 1000 precision saw (Buehler, Lake Bluff, IL) with a diamond 
blade. The final height was not to exceed 87mm (Appendix B). To ensure no movement 
occurred during scanning, all bones were wrapped and secured with parafilm. Clay 
markers were employed to indicate the anterior and medial sides of the tibiae. Femora 
and tibiae were imaged at the mid-shaft using a SkyScan 1172 (Bruker, Billerica, MA) 
desktop µCT system at 5.49 µm resolution. Subsequent scan data was placed into a 
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custom workflow using various image processing software programs (e.g., Nrecon 
(Bruker, Billerica, MA), ImageJ (NIH, Bethesda, MD), and CTAnalyser (Omicron, Klaus, 
Austria)) to convert the X-ray projections into 3D models of vascular pore networks 
(Appendix C; Appendix D). This workflow provided an image stack of two-dimensional 
(2D) cross-sections (1,000-1,200 slices) of the rabbit femora and tibiae representing the 
pore networks within the bone. Cross-sections that were obtained represent 
approximately 6.5mm length of bone at the mid-shaft of the femora and tibiae.  
 
Data Extraction  
 Cross-sections generated from the workflow were uploaded to Amira 6.0 
(Thermo Fisher Scientific, Waltham, MA) which produced 3D renders of the pore 
networks (Appendix E). The auto-skeleton feature created a spatial graph of the bone’s 
pore network throughout the cross-sections. The spatial graph was then analyzed to 
generate data for length of branches, number of branches, connectivity of network, and 
thickness of the branches. Data for each index of each individual bone was averaged to 
generate the mean and the median.  
 
Statistical Analyses  
 Pore systems among treatment groups (control, fentanyl, morphine) were 
analyzed by calculating the total, mean, median, maximum, and minimum for each 
index. A Shapiro-Wilk test and a Levene test were conducted in JMP Pro 14 (SAS 
Institute, Cary, NC) to ensure normal distribution of residuals and homogeneity of 
variance, respectively. Variables that violated the Shapiro-Wilk test or the Levene test 
were log transformed. Data met the assumptions of normality once log transformed, 
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however the assumption of homogeneity of variance remained violated. Although the 
assumption of homogeneity of variance was violated parametric statistics were applied. 
Mixed model statistical tests are robust to normality violations thus rationalizing 
proceeding with the log transformed data. Indices were compared among individuals by 
using a Repeated Measures ANOVA (RM-ANOVA) conducted in JMP Pro 14 (SAS 
Institute, Cary, NC). Treatment groups were analyzed using an RM-ANOVA to account 
for the repeated measurement of femur and tibia. A Tukey’s Honest Significance 
Differences (HSD) post-hoc pairwise comparison test revealed any significant 
differences between the treatment groups.  
IV. Results  
Due to this project being a part of a larger ongoing project in Dr. Janna 
Andronowski’s lab results cannot be reported at this time.  
V.  Discussion  
Due to this project being a part of a larger ongoing project in Dr. Janna 
Andronowski’s lab the discussion was excluded at this time.  
VI. Conclusion  
 Due to this project being a part of a larger ongoing project in Dr. Janna 
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